Inventor · disambiguated record
Karl Wassmann
Also filed as: WASSMANN KARL
1 granted patent·20 pending applications·8 citations·filing 2006–2023
30Inventor score
Files withBANKAITIS-DAVIS DANUTE M6BEVILACQUA MICHAEL3SOURCE PREC MEDICINE INC D B A3SOURCE PRECISION MEDICINE INC23D SYSTEMS INC1
Top patents by PatentIndex Score
21 records- 0179US7935482B2Gene expression profiling for identification monitoring and treatment of rheumatoid arthritisSOURCE PRECISION MEDICINE INC·Filed 2006·Granted May 3, 2011·8 cites·9 claims
- 0254US2008227655A1Assessment of effect of an agent on a human biological condition using rodent gene expression panelsBEVILACQUA MICHAEL·Filed 2007·Application pending·0 cites
- 0353US2023397928A1Skin Core Micro-Coring SystemSPERRY BIO INC·Filed 2023·Application pending·0 cites
- 0451US2014024547A1Gene Expression Profiling For Identification, Monitoring And Treatment Of Colorectal CancerGENENEWS CORP·Filed 2013·Application pending·0 cites
- 0550US2022183712A1Carrier Matrix for Facilitating Transfer of Skin Cores from Donor Site to Wound Site3D SYSTEMS INC·Filed 2021·Application pending·0 cites
- 0650US2011092390A1Assessment of effect of an agent on a human biological condition using rodent gene expression panelsSOURCE PRECISION MEDICINE INC·Filed 2010·Application pending·0 cites
- 0749US2008070243A1Gene expression profiling for identification, monitoring and treatment of multiple sclerosisBEVILACQUA MICHAEL·Filed 2006·Application pending·0 cites
- 0847US2011306512A1Gene Expression Profiling for Identification, Monitoring, and Treatment of OsteoarthritisBANKAITIS-DAVIS DANUTE M·Filed 2009·Application pending·0 cites
- 0947US2010196889A1Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal CancerBANKAITIS-DAVIS DANUTE M·Filed 2006·Application pending·0 cites
- 1046US2010248225A1Gene expression profiling for identification, monitoring and treatment of melanomaBANKAITIS-DAVIS DANUTE M·Filed 2007·Application pending·0 cites
- 1144US2021244432A1Skin construct transfer system and methodMASSACHUSETTS GEN HOSPITAL·Filed 2019·Application pending·0 cites
- 1242US2010233691A1Gene Expression Profiling for Identification, Monitoring and Treatment of Prostate CancerSOURCE PREC MEDICINE INC D B A·Filed 2007·Application pending·0 cites
- 1342US2010255470A1Gene Expression Profiling for Identification, Monitoring and Treatment of Breast CancerSOURCE PERCISION MEDICINE INC·Filed 2007·Application pending·0 cites
- 1442US2010330558A1Gene Expression Profiling for Identification, Monitoring and Treatment of Cervical CancerBANKAITIS-DAVIS DANUTE M·Filed 2007·Application pending·0 cites
- 1542US2010184034A1Gene Expression Profiling for Identification, Monitoring and Treatment of Lung CancerSOURCE PREC MEDICINE INC D B A·Filed 2007·Application pending·0 cites
- 1642US2010216137A1Gene Expression Profiling for Identification, Monitoring and Treatment of Ovarian CancerSOURCE PREC MEDICINE INC D B A·Filed 2007·Application pending·0 cites
- 1742US2010209915A1Gene Expression Profiling for Identification, Monitoring, and Treatment of Ocular DiseaseBANKAITIS-DAVIS DANUTE M·Filed 2007·Application pending·0 cites
- 1838US2012009581A1Gene Expression Profiling for Predicting the Survivability of Prostate Cancer SubjectsBANKAITIS-DAVIS DANUTE M·Filed 2009·Application pending·0 cites
- 1935US2008183395A1Gene expression profiling for identification, monitoring and treatment of multiple sclerosisBEVILACQUA MICHAEL·Filed 2007·Application pending·0 cites
- 2029US2011070582A1Gene Expression Profiling for Predicting the Response to Immunotherapy and/or the Survivability of Melanoma SubjectsSOURCE PREC MEDICINE INC D B D SOURCE MDX·Filed 2010·Application pending·0 cites
- 2121US2020190585A1Data Processing and Classification for Determining a Likelihood Score for Immune-Related Adverse EventsCHECKPOINT SCIENCES INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karl Wassmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →